Shoker Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.44M Sell
18,168
-947
-5% -$221K 1.32% 20
2025
Q4
$3.96M Sell
19,115
-322
-2% -$63.7K 1.16% 22
2025
Q3
$3.6M Buy
19,437
+32
+0.2% +$5.48K 1.06% 21
2025
Q2
$2.96M Buy
19,405
+258
+1% +$39.7K 0.93% 32
2025
Q1
$3.18M Buy
19,147
+576
+3% +$90.1K 1.07% 29
2024
Q4
$2.69M Buy
18,571
+226
+1% +$35K 0.91% 36
2024
Q3
$2.97M Sell
18,345
-501
-3% -$79.8K 1% 34
2024
Q2
$2.75M Buy
18,846
+221
+1% +$32.9K 0.97% 32
2024
Q1
$2.94M Buy
18,625
+127
+0.7% +$20.2K 1.05% 28
2023
Q4
$2.9M Buy
18,498
+120
+0.7% +$18.4K 1.12% 29
2023
Q3
$2.86M Sell
18,378
-173
-0.9% -$28.5K 1.24% 23
2023
Q2
$3.07M Buy
18,551
+128
+0.7% +$20.7K 1.28% 22
2023
Q1
$2.86M Buy
18,423
+66
+0.4% +$10.7K 1.25% 26
2022
Q4
$3.24M Sell
18,357
-93
-0.5% -$16.1K 1.45% 17
2022
Q3
$3.01M Buy
18,450
+526
+3% +$89K 1.58% 18
2022
Q2
$3.18M Buy
17,924
+356
+2% +$63.4K 1.69% 15
2022
Q1
$3.11M Sell
17,568
-890
-5% -$151K 1.54% 18
2021
Q4
$3.16M Sell
18,458
-174
-0.9% -$28.5K 1.45% 19
2021
Q3
$3.01M Sell
18,632
-274
-1% -$46.7K 1.5% 17
2021
Q2
$3.11M Buy
18,906
+193
+1% +$32K 1.55% 14
2021
Q1
$3.08M Sell
18,713
-252
-1% -$40.8K 1.61% 13
2020
Q4
$2.98M Sell
18,965
-25
-0.1% -$3.69K 1.67% 14
2020
Q3
$2.83M Sell
18,990
-439
-2% -$65K 1.85% 11
2020
Q2
$2.73M Buy
19,429
+101
+0.5% +$14.7K 1.9% 12
2020
Q1
$2.53M Buy
19,328
+1,300
+7% +$184K 2.13% 8
2019
Q4
$2.63M Sell
18,028
-4
-0% -$543 1.75% 14
2019
Q3
$2.33M Buy
18,032
+89
+0.5% +$11.7K 1.67% 15
2019
Q2
$2.5M Buy
17,943
+57
+0.3% +$7.89K 1.82% 14
2019
Q1
$2.5M Buy
17,886
+60
+0.3% +$8.04K 1.85% 15
2018
Q4
$2.3M Sell
17,826
-414
-2% -$57.8K 1.93% 12
2018
Q3
$2.52M Buy
18,240
+48
+0.3% +$6.38K 1.83% 14
2018
Q2
$2.21M Sell
18,192
-237
-1% -$29.6K 1.64% 16
2018
Q1
$2.36M Sell
18,429
-219
-1% -$29.6K 1.79% 13
2017
Q4
$2.6M Sell
18,648
-622
-3% -$86.6K 1.88% 12
2017
Q3
$2.5M Sell
19,270
-621
-3% -$82.3K 1.9% 12
2017
Q2
$2.63M Buy
19,891
+599
+3% +$76.4K 2.07% 11
2017
Q1
$2.4M Sell
19,292
-1,478
-7% -$177K 2.02% 11
2016
Q4
$2.39M Sell
20,770
-261
-1% -$30.1K 1.98% 11
2016
Q3
$2.48M Sell
21,031
-28
-0.1% -$3.4K 2.11% 11
2016
Q2
$2.55M Sell
21,059
-22
-0.1% -$2.5K 2.27% 11
2016
Q1
$2.28M Buy
21,081
+470
+2% +$48.7K 2.15% 9
2015
Q4
$2.12M Buy
20,611
+162
+0.8% +$16.3K 2.12% 10
2015
Q3
$1.91M Sell
20,449
-716
-3% -$69.3K 2.01% 14
2015
Q2
$2.06M Sell
21,165
-59
-0.3% -$5.91K 1.94% 13
2015
Q1
$2.13M Buy
21,224
+295
+1% +$30K 2.03% 13
2014
Q4
$2.19M Sell
20,929
-59
-0.3% -$6.22K 2.03% 13
2014
Q3
$2.24M Sell
20,988
-18
-0.1% -$1.87K 2.07% 13
2014
Q2
$2.2M Buy
21,006
+128
+0.6% +$12.9K 1.95% 14
2014
Q1
$2.05M Buy
20,878
+216
+1% +$20K 1.93% 12
2013
Q4
$1.89M Buy
+20,662
New +$1.9M 1.74% 13

Other funds holding JNJ

Shoker Investment Counsel's JNJ Position: Q1 2026 in Review

Shoker Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 5% in Q1 2026, selling an estimated $221K and leaving 18,168 shares worth $4.44M. The position accounts for 1.32% of the portfolio, ranked #20.

Shoker Investment Counsel first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Shoker Investment Counsel held 18,168 shares of Johnson & Johnson worth $4.44M as of Q1 2026.
  • Shoker Investment Counsel sold 947 Johnson & Johnson shares in Q1 2026, an estimated $221K.
  • Johnson & Johnson made up 1.32% of Shoker Investment Counsel's portfolio in Q1 2026, its #20 holding.
  • Shoker Investment Counsel first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Shoker Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.